Publication | Closed Access

Clinical effects and kinetic properties of intravenous APSAC — anisoylated plasminogen-streptokinase activator complex (BRL 26921) in acute myocardial infarction

ThrombosisMolecular PharmacologyCardiovascular DiseaseBiochemistryBrl 26921MedicineCardiovascular PharmacologyPharmacotherapyPharmacologyCardiologyIntravenous Apsac —Acute Myocardial InfarctionMyocardial Infarction